These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 30012954
1. Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma. Corrales P, Izquierdo-Lahuerta A, Medina-Gómez G. Int J Mol Sci; 2018 Jul 16; 19(7):. PubMed ID: 30012954 [Abstract] [Full Text] [Related]
2. Effects of PPARγ agonists against vascular and renal dysfunction. Sugawara A, Uruno A, Matsuda K, Saito-Ito T, Funato T, Saito-Hakoda A, Kudo M, Ito S. Curr Mol Pharmacol; 2012 Jun 16; 5(2):248-54. PubMed ID: 22122454 [Abstract] [Full Text] [Related]
9. Can PPARgamma agonists have a role in the management of obesity-related hypertension? Chetty VT, Sharma AM. Vascul Pharmacol; 2006 Jul 16; 45(1):46-53. PubMed ID: 16713364 [Abstract] [Full Text] [Related]
10. The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review. Liu Y, Wang J, Luo S, Zhan Y, Lu Q. J Autoimmun; 2020 Sep 16; 113():102510. PubMed ID: 32622513 [Abstract] [Full Text] [Related]
11. PPAR(gamma) and glucose homeostasis. Picard F, Auwerx J. Annu Rev Nutr; 2002 Sep 16; 22():167-97. PubMed ID: 12055342 [Abstract] [Full Text] [Related]
12. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs). Huang TH, Roufogalis BD. Curr Mol Pharmacol; 2012 Jun 16; 5(2):241-7. PubMed ID: 22122453 [Abstract] [Full Text] [Related]
13. The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor. Dobrian AD. Vascul Pharmacol; 2006 Jul 16; 45(1):36-45. PubMed ID: 16716756 [Abstract] [Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears. Mao Z, Ong AC. Nephron Clin Pract; 2009 Jul 16; 112(4):c230-41. PubMed ID: 19546582 [Abstract] [Full Text] [Related]
15. PPAR-gamma in ulcerative colitis: a novel target for intervention. Bertin B, Dubuquoy L, Colombel JF, Desreumaux P. Curr Drug Targets; 2013 Nov 16; 14(12):1501-7. PubMed ID: 23651165 [Abstract] [Full Text] [Related]
16. Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells. Casali CI, Weber K, Faggionato D, Gómez EM, Tome MC. Biochem Pharmacol; 2014 Aug 15; 90(4):432-9. PubMed ID: 24915420 [Abstract] [Full Text] [Related]
18. [The role of PPARgamma agonists in kidney diseases]. Yokoyama Y, Doi S, Kawai T, Yorioka N. Nihon Rinsho; 2010 Feb 15; 68(2):317-22. PubMed ID: 20158103 [Abstract] [Full Text] [Related]